Home

fonds Ironisch heel veel fibrosis in liver disease nature review PapoeaNieuwGuinea suiker onwettig

Pathophysiology of liver fibrosis. After chronic liver injury, necrotic...  | Download Scientific Diagram
Pathophysiology of liver fibrosis. After chronic liver injury, necrotic... | Download Scientific Diagram

Immunological mechanisms and therapeutic targets of fatty liver diseases |  Cellular & Molecular Immunology
Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology

Epigenetic reprogramming in liver fibrosis and cancer - ScienceDirect
Epigenetic reprogramming in liver fibrosis and cancer - ScienceDirect

Nonalcoholic fatty liver disease | Nature Reviews Disease Primers
Nonalcoholic fatty liver disease | Nature Reviews Disease Primers

Resolving the fibrotic niche of human liver cirrhosis at single-cell level  | Nature
Resolving the fibrotic niche of human liver cirrhosis at single-cell level | Nature

Frontiers | Therapeutic Targeting of Hepatic Macrophages for the Treatment  of Liver Diseases | Immunology
Frontiers | Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases | Immunology

EASL Clinical Practice Guideline: Occupational liver diseases - Journal of  Hepatology
EASL Clinical Practice Guideline: Occupational liver diseases - Journal of Hepatology

Acute-on-chronic liver failure: terminology, mechanisms and management | Nature  Reviews Gastroenterology & Hepatology
Acute-on-chronic liver failure: terminology, mechanisms and management | Nature Reviews Gastroenterology & Hepatology

Hepatic fibrosis: Concept to treatment - ScienceDirect
Hepatic fibrosis: Concept to treatment - ScienceDirect

Acute-on-chronic liver failure in cirrhosis | Nature Reviews Disease Primers
Acute-on-chronic liver failure in cirrhosis | Nature Reviews Disease Primers

Nature Reviews Gastroenterology & Hepatology on Twitter: "REVIEW | Gut  #microbiota and human #NAFLD: disentangling microbial signatures from  metabolic disorders by @ClementLab & colleagues https://t.co/BhjImLZrG0…  https://t.co/O3G6TQUOXN"
Nature Reviews Gastroenterology & Hepatology on Twitter: "REVIEW | Gut #microbiota and human #NAFLD: disentangling microbial signatures from metabolic disorders by @ClementLab & colleagues https://t.co/BhjImLZrG0… https://t.co/O3G6TQUOXN"

Nature Reviews Gastroenterology & Hepatology on Twitter: "#TrendingNow  @DrLoomba and @ebtapper review the #elastographic assessment of liver  fibrosis in #NAFLD and discuss the clinical position of specific techniques  £ https://t.co/DSXUwHsBD6… https ...
Nature Reviews Gastroenterology & Hepatology on Twitter: "#TrendingNow @DrLoomba and @ebtapper review the #elastographic assessment of liver fibrosis in #NAFLD and discuss the clinical position of specific techniques £ https://t.co/DSXUwHsBD6… https ...

Microbiome Signatures Associated With Steatohepatitis and Moderate to  Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease -  Gastroenterology
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease - Gastroenterology

Management of NAFLD: a stage-based approach | Nature Reviews  Gastroenterology & Hepatology
Management of NAFLD: a stage-based approach | Nature Reviews Gastroenterology & Hepatology

Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic  fibrosis in experimental advanced chronic liver disease - Journal of  Hepatology
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology

Non-alcoholic fatty liver disease - Wikiwand
Non-alcoholic fatty liver disease - Wikiwand

A story of liver and gut microbes: how does the intestinal flora affect liver  disease? A review of the literature | American Journal of  Physiology-Gastrointestinal and Liver Physiology
A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature | American Journal of Physiology-Gastrointestinal and Liver Physiology

Frontiers | The Roles of Liver-Resident Lymphocytes in Liver Diseases |  Immunology
Frontiers | The Roles of Liver-Resident Lymphocytes in Liver Diseases | Immunology

MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a  multidisciplinary approach towards a cardiometabolic liver disease in:  European Journal of Endocrinology Volume 183 Issue 3 (2020)
MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease in: European Journal of Endocrinology Volume 183 Issue 3 (2020)

Nature Reviews Gastroenterology & Hepatology בטוויטר: "KEY ADVANCE: "The  altered gut #microbiota profile is associated with systemic inflammation in  patients with nonalcoholic fatty liver disease (#NAFLD)-related cirrhosis  who have hepatocellular ...
Nature Reviews Gastroenterology & Hepatology בטוויטר: "KEY ADVANCE: "The altered gut #microbiota profile is associated with systemic inflammation in patients with nonalcoholic fatty liver disease (#NAFLD)-related cirrhosis who have hepatocellular ...

Liver fibrosis and repair: immune regulation of wound healing in a solid  organ | Nature Reviews Immunology
Liver fibrosis and repair: immune regulation of wound healing in a solid organ | Nature Reviews Immunology

Limitations of non-invasive tests for assessment of liver fibrosis - JHEP  Reports
Limitations of non-invasive tests for assessment of liver fibrosis - JHEP Reports

Liver fibrosis: Pathophysiology and clinical implications - Berumen - 2021  - WIREs Mechanisms of Disease - Wiley Online Library
Liver fibrosis: Pathophysiology and clinical implications - Berumen - 2021 - WIREs Mechanisms of Disease - Wiley Online Library

Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype  in a BALB/c.Abcb4-/- mouse model of PFIC3 - Journal of Hepatology
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3 - Journal of Hepatology

Non-alcoholic fatty liver disease: an emerging driving force in chronic  kidney disease | Nature Reviews Nephrology
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease | Nature Reviews Nephrology